tirzepatide launch Cipla launches Yurpeak® (tirzepatide), a one-weekly injectable therapy for managing obesity and type 2 diabetes mellitus (T2DM) — two of the country's most pressing health challenges. Cipla has the rights to distribute Tirzepatide | DirectMeds

Learn More DMAE Firming Gel An exclusive Rx-compounded 3% gel, combining DMAE with hyaluronic and alpha lipoic acids for firmer, smoother-looking skinbuilt on the idea that skin ages at the cellular level, not just the surface

I left a message and never received a callback

Research indicates that individuals may lose approximately 6-8% of their body weight within this timeframe

This blog discusses each individual's unique contributions and how they can help general wellness

Medically reviewed by Alan Lucks | MD , Alan Lucks MDPC Private Practice - New York on October 10th, 2025

Disclaimer: This content is for general information only and is not medical advice